Mable Beal v. Walgreen Company

408 F. App'x 898
CourtCourt of Appeals for the Sixth Circuit
DecidedNovember 10, 2010
Docket09-5899
StatusUnpublished
Cited by10 cases

This text of 408 F. App'x 898 (Mable Beal v. Walgreen Company) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mable Beal v. Walgreen Company, 408 F. App'x 898 (6th Cir. 2010).

Opinion

OPINION

KAREN NELSON MOORE, Circuit Judge.

In this diversity case, Mable B. Beal, deceased (through representative Deborah K. Putnam), and Ruth M. Schaeffer, deceased 1 (through representative Doris Bicknell), (collectively, the “Plaintiffs”) challenge the district court’s partial grant of summary judgment for the Plaintiffs and for the defendant, Walgreen Company (“Walgreens”). This case arises from state-law causes of action for medical malpractice that the Plaintiffs filed separately in Tennessee state court in 2002 against Walgreens for improperly filled prescriptions. Plaintiff Beal, then seventy-five years of age, presented a handwritten prescription from her urologist for Imipramine to a Walgreens pharmacist in 2001, but the pharmacist erroneously read the drug name as Imuran and dispensed Imuran to Beal. Beal did not receive counseling at the time she picked up her prescription, and she took the entire prescribed dose and part of one refill before she went to the emergency room complaining of symptoms of swelling in her legs, feet, and abdomen; weight gain; and shortness of breath. The emergency-room doctor recognized that Imuran was not a drug prescribed for bladder problems, and Beal *900 stopped taking Imuran. Beal alleges that her health improved after she stopped taking Imuran and began taking Imipramine, but that, prior to her death in 2008, she never fully recovered from the congestive-heart-failure complications that Imuran caused. Plaintiff Schaeffer, then ninety-three years of age, presented a prescription for a manufacturer-created Uro-Pac dosage of Floxin to a different Walgreens pharmacist in 2001, but because the Uro-Pac was unavailable at that location, the pharmacist offered to create a simulated dose pack. Schaeffer’s son-in-law, who presented the prescription, accepted this option, but the pharmacist miscalculated the number of pills required and created a dose pack with dosage directives greater than prescribed. Schaeffer took the dose pack until another son-in-law recognized that she was taking too large of a dosage after she complained of nausea and vomiting. Schaeffer alleges that she never fully recovered prior to her death in 2002.

The Plaintiffs’ separate state-court causes of action against Walgreens were later consolidated. Following several procedural setbacks, the Plaintiffs each non-suited their state cases in November 2004 and then filed one case together in federal court in March 2005 asserting several causes of action related to the same underlying conduct alleged in their separate state-court cases. The district court granted Walgreens’ motion requesting that it decline to exercise jurisdiction in light of Plaintiff Beal’s then-pending state-court appeal, and the district court dismissed the case without prejudice to the Plaintiffs refiling in state court. The Plaintiffs refiled their claims in state court in August 2006, but the court dismissed their complaints in February 2007 as barred by the state statute of limitations. The Plaintiffs immediately filed a Federal Rule of Civil Procedure 60 motion in the district court to set aside the dismissal order, and the district court “restored [the case] to the docket for further administration” in July 2007 before later vacating its dismissal order. Dist. Ct. Doc. (“Doc.”) 60; Doc. 73. The Sixth Circuit declined to accept Walgreens’ interlocutory appeal from this order, and the case continued in the district court.

The Plaintiffs then filed an amended-complaint and a motion for summary judgment on compensatory and punitive damages, the disposition of which is at issue in this appeal. In response, Walgreens moved under state law to strike the affidavit of the Plaintiffs’ expert, clinical pharmacist Dr. Bob Lobo, and under Federal Rule of Civil Procedure 56 to strike the affidavits from four deceased affiants. Walgreens also filed a cross-motion for summary judgment on punitive damages. In one order, the district court granted Walgreens’ motions to strike the affidavits and ruled on the dueling summary-judgment motions. The court denied summary judgment to Plaintiff Beal on all of her claims because it concluded that Plaintiff Beal could not prove the causation element of her medical-malpractice case. But the court concluded that Plaintiff Schaeffer’s treating physician had adequately opined as to causation and granted summary judgment to Plaintiff Schaeffer on compensatory damages in an amount to be determined at trial. Even so, the court ruled that neither Plaintiff was entitled to punitive damages under Tennessee law and granted summary judgment to Walgreens on both Plaintiffs’ punitive-damages claims. The district court then entered a Federal Rule of Civil Procedure 54(b) final judgment so that the Plaintiffs could pursue this appeal, stressing the fact that the Plaintiffs explained in their unopposed Rule 54(b) motion that they will dismiss all claims with prejudice if this court affirms the district court’s punitive-damages ruling.

*901 The Plaintiffs assert on appeal the eight issues that they proposed in their Rule 54(b) motion, but, as stated in their motion, their main contention is that the district court incorrectly interpreted Tennessee law on punitive damages in holding that neither Plaintiff was entitled to recover such damages as a matter of law. Because we affirm the district court’s punitive-damages ruling upon which the Plaintiffs have hinged the continuing viability of the instant case, we decline to reach the other, non-dispositive issues that the Plaintiffs raised.

ANALYSIS

We review a district court’s summary-judgment decision de novo, applying the substantive law of the forum state and federal procedural law in diversity cases. 2 Biegas v. Quickway Carriers, Inc., 573 F.3d 365, 373-74 (6th Cir.2009). Under *902 Federal Rule of Civil Procedure 56(c), summary judgment is appropriate “if the pleadings, the discovery and disclosure materials on file, and any affidavits show that there is no genuine issue as to any material fact and that the movant is entitled to judgment as a matter of law.” Fed.R.Civ.P. 56(c). As we have stated:

“The burden is generally on the moving party to show that no genuine issue of material fact exists, but that burden may be discharged by ‘showing — that is, pointing out to the district court — that there is an absence of evidence to support the nonmoving party’s case.’ Celotex Corp. v. Catrett, 477 U.S. 317, 325, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986) (internal quotation marks omitted). In reviewing a summary judgment motion, credibility judgments and weighing of the evidence are prohibited. Rather, the evidence should be viewed in the light most favorable to the non-moving party.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
408 F. App'x 898, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mable-beal-v-walgreen-company-ca6-2010.